Bryan Hanson leads QuidelOrtho’s global business unit portfolio, with responsibility for strategy, performance and growth across clinical laboratories, transfusion medicine, point of care and molecular diagnostics. He drives enterprise-wide execution with full accountability for revenue, profitability and global market share.

With more than 18 years across QuidelOrtho and its legacy companies, Mr. Hanson has built a track record of scaling businesses, accelerating adoption of advanced diagnostic technologies and delivering sustained financial performance. Most recently, as Senior Vice President of Clinical Labs and Transfusion Medicine, he led the expansion and adoption of diagnostic technologies while accelerating sustained revenue growth. Before that, he held leadership roles in sales, marketing and operations at Johnson & Johnson and Ortho Clinical Diagnostics.

Mr. Hanson holds a bachelor’s degree in business administration from the University of North Dakota and a certificate in strategic marketing management from The Wharton School of the University of Pennsylvania.